TF and congenital disorder of glycosylation: Serum transferrin and total serum N-glycans have also been proposed as IGD biomarkers given their sensitivity for other congenital disorders of glycosylation (CDG) with N-glycosylation defects.79 Whilst clinically useful for the exclusion of these disorders, we report their limited diagnostic sensitivity for the IGDs.